Federal health officials say the risk to the general American public remains low following a hantavirus response involving repatriated passengers and cruise ship travelers, according to the Centers for Disease Control and Prevention. The agency activated an emergency response involving more than 100 staff members after receiving notification of the outbreak.
Federal Response and International Coordination
According to CDC Incident Manager Dr. David Fitter, the agency mobilized immediately after international health regulations notification. The CDC coordinated with state and public health authorities, federal partners including the Administration for Strategic Preparedness and Response (ASPR) and the State Department, and international health partners.
A specialized CDC team deployed directly to the Canary Islands to conduct on-site public health assessments and speak individually with United States citizens regarding potential exposures. Two team members accompanied American passengers on a repatriation flight to Nebraska, where another CDC team met the aircraft to manage ongoing health evaluations, according to agency officials.
Monitoring Protocols and Incubation Periods
Medical epidemiologist and CDC Nebraska team lead Dr. Brendan Jackson noted that the monitoring period spans 42 days due to the virus’s long incubation window. Day one of the monitoring protocol began on May 11, matching the departure date from the ship.
Staff at the University of Nebraska Medical Center in Omaha are conducting regular temperature checks, symptom screenings, and general wellness evaluations. According to Dr. Fitter, health authorities are encouraging travelers to utilize designated facilities or quarantine at home while working closely with state and local health departments for daily monitoring.
Testing Guidelines and Diagnostic Procedures
The CDC currently recommends diagnostic testing exclusively for individuals presenting with symptoms and an identified exposure risk, according to agency briefings. A validated blood test specifically for Andes virus exists, while a PCR test remains classified for research use only and is not yet deployed for direct patient care.
Regarding initial testing of repatriated travelers, federal officials reported that preliminary test results received from abroad were inconclusive. Additional domestic testing was initiated to establish clear health dispositions, with results expected within a short turnaround window.
Keep reading